Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00402883
Status:
TERMINATED
Last Update Posted:
2021-11-09
First Post:
2006-11-21
Brief Title:
Chemotherapy Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Cancer |
Keywords: